Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment related fluctuations in Guillain-Barré syndrome after high-dose immunoglobulins or plasma-exchange.

Literature DB >> 1800666

Treatment related fluctuations in Guillain-Barré syndrome after high-dose immunoglobulins or plasma-exchange.

Abstract

Since the introduction of plasma exchange as a treatment for Guillain-Barré syndrome (GBS) patients, treatment related fluctuations have been found to occur in about 10% of the patients. These fluctuations are considered additional evidence of the beneficial effect of plasma exchange. In this report the occurrence of such treatment related fluctuations is described in the 147 patients who took part in the Dutch Guillain-Barré trial comparing high dose intravenous immunoglobulin with plasma exchange. Six of 72 patients in the plasma exchange group and eight of 74 in the immunoglobulin group showed such fluctuation. These results support the biological effect of immunoglobulin. More general use of immunoglobulin should await the full analysis of the Dutch GBS trial which is in progress.

Entities: Disease Species

Mesh：

Substances：

Year: 1991 PMID： 1800666 PMCID： PMC1014615 DOI： 10.1136/jnnp.54.11.957

Source DB: PubMed Journal: J Neurol Neurosurg Psychiatry ISSN： 0022-3050 Impact factor: 10.154

13 in total

1. Landry-Guillain-Barré-Strohl syndrome. A study of 302 cases.

Authors: S K Samantray; S C Johnson; K V Mathai; B M Pulimood
Journal: Med J Aust Date: 1977-07-16 Impact factor: 7.738

2. A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value.

Authors: J B Winer; R A Hughes; C Osmond
Journal: J Neurol Neurosurg Psychiatry Date: 1988-05 Impact factor: 10.154

3. Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases.

Authors: P A McCombe; J D Pollard; J G McLeod
Journal: Brain Date: 1987-12 Impact factor: 13.501

4. Early relapse of acute inflammatory polyradiculoneuropathy after successful treatment with plasma exchange.

Authors: P O Osterman; J Fagius; J Säfwenberg; B Wikström
Journal: Acta Neurol Scand Date: 1988-04 Impact factor: 3.209

5. [Clinical investigation of inflammatory polyradiculoneuritis in France].

Authors: P Castaigne; P Brunet; F Nouailhat
Journal: Rev Neurol (Paris) Date: 1966-10 Impact factor: 2.607

6. Limited relapse in Guillain-Barré syndrome after plasma exchange.

Authors: A E Ropper; J W Albert; R Addison
Journal: Arch Neurol Date: 1988-03

7. Chronic inflammatory demyelinating polyneuropathy. Conduction failure before and during immunoglobulin or plasma therapy.

Authors: F G van der Meché; M Vermeulen; H F Busch
Journal: Brain Date: 1989-12 Impact factor: 13.501

8. High-dose intravenous human immunoglobulin in chronic inflammatory demyelinating polyneuropathy.

Authors: J M Faed; B Day; M Pollock; P K Taylor; H Nukada; G D Hammond-Tooke
Journal: Neurology Date: 1989-03 Impact factor: 9.910

9. The natural history of the Guillain-Barré syndrome in 18 children and 50 adults.

Authors: R P Kleyweg; F G van der Meché; M C Loonen; J de Jonge; B Knip
Journal: J Neurol Neurosurg Psychiatry Date: 1989-07 Impact factor: 10.154

10. Treatment of Guillain-Barré syndrome with high-dose gammaglobulin.

Authors: R P Kleyweg; F G van der Meché; J Meulstee
Journal: Neurology Date: 1988-10 Impact factor: 9.910

19 in total

1. Guillain-Barré syndrome variants in Emilia-Romagna, Italy, 1992-3: incidence, clinical features, and prognosis. Emilia-Romagna Study Group on Clinical and Epidemiological Problems in Neurology.

Authors:
Journal: J Neurol Neurosurg Psychiatry Date: 1998-08 Impact factor: 10.154

Treatment related fluctuations in Guillain-Barré syndrome after high-dose immunoglobulins or plasma-exchange.

1. Landry-Guillain-Barré-Strohl syndrome. A study of 302 cases.

2. A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value.

3. Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases.

4. Early relapse of acute inflammatory polyradiculoneuropathy after successful treatment with plasma exchange.

5. [Clinical investigation of inflammatory polyradiculoneuritis in France].

6. Limited relapse in Guillain-Barré syndrome after plasma exchange.

7. Chronic inflammatory demyelinating polyneuropathy. Conduction failure before and during immunoglobulin or plasma therapy.

8. High-dose intravenous human immunoglobulin in chronic inflammatory demyelinating polyneuropathy.

9. The natural history of the Guillain-Barré syndrome in 18 children and 50 adults.

10. Treatment of Guillain-Barré syndrome with high-dose gammaglobulin.

1. Guillain-Barré syndrome variants in Emilia-Romagna, Italy, 1992-3: incidence, clinical features, and prognosis. Emilia-Romagna Study Group on Clinical and Epidemiological Problems in Neurology.

Review 2. Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis.

3. Intravenous immune globulin in the Guillain-Barré syndrome.

Review 4. The Guillain-Barré syndrome: plasma exchange or immunoglobulins intravenously.

5. High dose intravenous immune globulins and plasma exchange in Guillain-Barré Syndrome.

6. Natural history and treatment effects in Guillain-Barré syndrome: a multicentre study.

Review 7. Advances in the management of Guillain-Barré syndrome.

8. Inpatient management of guillain-barré syndrome.

Review 9. Guillain-Barré syndrome: epidemiology, pathophysiology and management.

10. Treatment-related fluctuation in Guillain-Barre syndrome.